+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

Myelodysplastic Syndrome Drug Market - Global Forecast 2025-2030 - Product Thumbnail Image

Myelodysplastic Syndrome Drug Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Wearable Injectors Market Industry Trends and Global Forecasts to 2035, by Type of Device, Usability, Therapeutic Area and Key Geographical Regions - Product Thumbnail Image

Wearable Injectors Market Industry Trends and Global Forecasts to 2035, by Type of Device, Usability, Therapeutic Area and Key Geographical Regions

  • Report
  • January 2025
  • 690 Pages
  • Global
From
Metastatic Melanoma Therapeutics Market Report 2025 - Product Thumbnail Image

Metastatic Melanoma Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Secretase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Secretase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 500 Pages +
  • Global
From
Overactive Bladder Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Overactive Bladder Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape - Product Thumbnail Image

Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape

  • Report
  • March 2023
  • 182 Pages
  • Global
From
Dissolvable Oral Thin Films Global Market Report 2023 - Product Thumbnail Image

Dissolvable Oral Thin Films Global Market Report 2023

  • Report
  • March 2023
  • 71 Pages
  • Global
Peripheral T-Cell Lymphoma Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Peripheral T-Cell Lymphoma Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 228 Pages
  • Global
From
Insomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Insomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 109 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 672 Pages
  • Global
From
Breast Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Breast Cancer Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 168 Pages
  • Global
From
Pruritus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pruritus Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 192 Pages
  • Global
From
Gastrointestinal Stromal Tumor (GIST) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastrointestinal Stromal Tumor (GIST) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 155 Pages
  • Global
From
Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2025 - Product Thumbnail Image

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 204 Pages
  • Global
From
Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 195 Pages
  • Global
From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 283 Pages
  • Global
Loading Indicator